SLC66A3 and hepatocellular carcinoma: Notably, we found SLC39A1 and SLC66A3, but not SLC50A1, were significantly upregulated in HCC‐relapsed patients and negatively associated with overall survival (OS) in the TCGA database (Figure 1A,B; Figure S2A–C).